Silver Nanoparticles Modify VEGF Signaling Pathway and Mucus Hypersecretion in Allergic Airway Inflammation
Overview
Authors
Affiliations
The anti-inflammatory action of silver nanoparticles (NPs) has been reported in a murine model of asthma in a previous study. But more specific mechanisms of silver NPs in an attenuation of allergic airway inflammation have not yet been established. Vascular and mucous changes are believed to contribute largely in pathophysiology in asthma. Among various factors related to vascular changes, vascular endothelial growth factor (VEGF) plays a pivotal role in vascular changes in asthma. Mucin proteins MUC5AC and MUC5B have been implicated as markers of goblet cell metaplasia in lung pathologies. The aim of this study was to investigate the effects of silver NPs on VEGF signaling pathways and mucus hypersecretion. Ovalbumin (OVA)-inhaled female BALBc mice were used to evaluate the role of silver NPs and the related molecular mechanisms in allergic airway disease. In this study, with an OVA-induced murine model of allergic airway disease, it was found that the increased levels of hypoxia-inducible factor (HIF)-1α, VEGF, phosphatidylinositol-3 kinase (PI3K) and phosphorylated-Akt levels, and mucous glycoprotein expression (Muc5ac) in lung tissues were substantially decreased by the administration of silver NPs. In summary, silver NPs substantially suppressed mucus hypersecretion and PI3K/HIF-1α/VEGF signaling pathway in an allergic airway inflammation.
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.
Cui L, Yang Y, Hao Y, Zhao H, Zhang Y, Wu T Clin Rev Allergy Immunol. 2025; 68(1):12.
PMID: 39928241 PMC: 11811441. DOI: 10.1007/s12016-024-09019-w.
Innovative approaches to asthma treatment: harnessing nanoparticle technology.
Goswami V, Sodhi K, Singh C Discov Nano. 2025; 20(1):21.
PMID: 39922940 PMC: 11807046. DOI: 10.1186/s11671-025-04211-z.
Zhao Y, Liu Y, Shan J, Xu X, Zhang C, Liu Z J Nanobiotechnology. 2025; 23(1):59.
PMID: 39881307 PMC: 11776288. DOI: 10.1186/s12951-024-03087-y.
Histochemistry for Molecular Imaging in Nanomedicine.
Malatesta M Int J Mol Sci. 2024; 25(15).
PMID: 39125610 PMC: 11311594. DOI: 10.3390/ijms25158041.
Nagaiah H, Periyakaruppan Murugesan P, Ravindra Rupali C, Shunmugiah K AAPS J. 2024; 26(4):67.
PMID: 38862870 DOI: 10.1208/s12248-024-00936-4.